Esoxybutynin

N/A

Report date: 2026/02/09 20:01:27
NME

Base Information

Drug NameEsoxybutynin
Drug Alias NameS-Oxybutynin(S)-Oxybutynin
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary IncontinenceUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUrinary IncontinenceUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A